Search research articles
Contact Us
Filters
Showing results (11-20 of 37) with videos related to
Page
of 4
Sort By:
Health Policy (Amsterdam, Netherlands)
|
March 8, 1998
The German experience in reference pricing
G Giuliani, G Selke, L Garattini
Italian Journal of Neurological Sciences
|
August 10, 2000
The economic cost of epilepsy: a review
M Brunetti, E Pagano, L Garattini
Epidemiologia E Prevenzione
|
February 24, 2001
[Health status indicators: features of the economic approach]
S Ghislandi, G Bertolini, L Garattini
European Journal of Cancer Care
|
February 13, 2010
Healthcare costs of multiple myeloma: an Italian study
D Koleva, S Cortelazzo, C Toldo, et al.
Pharmacoeconomics
|
December 9, 1994
A proposal for Italian guidelines in pharmacoeconomics The Mario Negri Institute Centre for Health Economics
L Garattini, R Grilli, D Scopelliti, et al.
Pharmacoeconomics
|
June 6, 1997
Economic evaluation of ACE inhibitor treatment of nephropathy in patients with insulin-dependent diabetes mellitus in Italy
L Garattini, M Brunetti, F Salvioni, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 21, 2004
Is EQ-5D a valid measure of HRQoL in patients with movement disorders? A comparison with SF-36 and FIM questionnaires
S Ghislandi, G Apolone, L Garattini, et al.
Pharmacoeconomics
|
January 8, 1996
Economic evaluation of an educational campaign for early diagnosis of cutaneous melanoma
L Garattini, T Cainelli, G Tribbia, et al.
Pharmacoeconomics
|
October 5, 1994
A comparative analysis of the pharmaceutical market in four European countries
L Garattini, F Salvioni, D Scopelliti, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 21, 2004
Pharmacoeconomic analysis of prescriptions in Italian pediatric general practice
R Campi, L Garattini, F Tediosi, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 37) with videos related to
Sort By:
Page
of 4
Health Policy (Amsterdam, Netherlands)
|
March 8, 1998
The German experience in reference pricing
G Giuliani, G Selke, L Garattini
Italian Journal of Neurological Sciences
|
August 10, 2000
The economic cost of epilepsy: a review
M Brunetti, E Pagano, L Garattini
Epidemiologia E Prevenzione
|
February 24, 2001
[Health status indicators: features of the economic approach]
S Ghislandi, G Bertolini, L Garattini
European Journal of Cancer Care
|
February 13, 2010
Healthcare costs of multiple myeloma: an Italian study
D Koleva, S Cortelazzo, C Toldo, et al.
Pharmacoeconomics
|
December 9, 1994
A proposal for Italian guidelines in pharmacoeconomics The Mario Negri Institute Centre for Health Economics
L Garattini, R Grilli, D Scopelliti, et al.
Pharmacoeconomics
|
June 6, 1997
Economic evaluation of ACE inhibitor treatment of nephropathy in patients with insulin-dependent diabetes mellitus in Italy
L Garattini, M Brunetti, F Salvioni, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 21, 2004
Is EQ-5D a valid measure of HRQoL in patients with movement disorders? A comparison with SF-36 and FIM questionnaires
S Ghislandi, G Apolone, L Garattini, et al.
Pharmacoeconomics
|
January 8, 1996
Economic evaluation of an educational campaign for early diagnosis of cutaneous melanoma
L Garattini, T Cainelli, G Tribbia, et al.
Pharmacoeconomics
|
October 5, 1994
A comparative analysis of the pharmaceutical market in four European countries
L Garattini, F Salvioni, D Scopelliti, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
December 21, 2004
Pharmacoeconomic analysis of prescriptions in Italian pediatric general practice
R Campi, L Garattini, F Tediosi, et al.
Page
of 4